Craig L. Bennett
Biography
Craig L. Bennett, Ph.D., is Associate Adjunct Professor in the Department of Pathology at the University of California, Irvine, where he serves as Drug Development Manager for the UC Irvine Center for Neurotherapeutics. Bennett received his Ph.D. in Molecular Genetics from The University of Sydney in 1998. His research career has focused on molecular genetics, genomics, and cell biology, with particular emphasis on inherited nervous system disorders and motor neuron disease. He has authored approximately 50 scientific publications and serves on scientific review panels for neurodegenerative disease research for the NIH, the Muscular Dystrophy Association, and the Department of Defense.
Bennett's research has concentrated on understanding the genetic and molecular mechanisms underlying amyotrophic lateral sclerosis (ALS) and related neurodegenerative disorders. His work has examined senataxin mutations in ALS4, a juvenile-onset form of familial ALS, and explored how these mutations affect RNA processing and motor neuron survival. He has developed mouse models to study ALS4 pathology and investigated the role of environmental factors, including the neurotoxin BMAA, in sporadic motor neuron disease. His research has demonstrated that senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in both mouse models and human patients.
Bennett has held faculty positions at multiple institutions, including Duke University, UC San Diego, James Cook University, and the University of Lincoln. He received a Muscular Dystrophy Association Research Development Fellowship from 1998 to 2001 and has served as principal investigator on numerous grants from the NIH, Muscular Dystrophy Association, and other funding agencies. He has served as external examiner for multiple doctoral and master's theses in ALS genetics and has mentored postdoctoral fellows, graduate students, and medical students throughout his career.
Return to topEducation
- B.Sc. in Biology, Macquarie University, 1990
- B.Sc.(Hons) 1st class in Molecular Biology, The University of Sydney, 1993
- Ph.D. in Molecular Genetics, The University of Sydney, 1998
- Grad.Dip.Edu in Science Education, Monash University, 2009
Distinctions
- Faculty1000 post-publication review: Travel Award (Genomics & Genetics), 2013
- Muscular Dystrophy Association Research Development Fellowship, 1998-2001
- Australian Postgraduate Research Award, 1994-1997
Areas of Expertise
- Neurodegenerative Disease Genetics
- Amyotrophic Lateral Sclerosis Pathogenesis
- Senataxin Helicase Function
- Motor Neuron Degeneration Mechanisms
- TDP-43 Protein Mislocalization
- Environmental Neurotoxin Exposure
- C9orf72 Dipeptide Repeat Toxicity
Recent Publications
- Bennett CL, Dastidar SG, Arnold F, McKinstry S, Stockford C, Freibaum BD, Sopher BL, Meilin Wu M, Seidner G, Joiner, Taylor JP, West RJH, La Spada AR, “Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 G4C2 and arginine-containing dipeptide repeat toxicity” (opens in new tab), Acta Neuropathologica Communications, vol. 11, no. 1, pp. 164, 2023.
- Arnold F, Nguyen AD, Bedlack RS, Bennett CL, La Spada AR, “Intercellular transmission of pathogenic proteins in ALS: exploring the pathogenic wave” (opens in new tab), Neurobiology of Disease, vol. 184, pp. 106218, 2023.
- Arnold F, Burns M, Chiu Y, Carvalho J, Ralph PC, La Spada AR, Bennett CL, “Chronic BMAA exposure combined with TDP-43 mutation elicits motor neuron dysfunction phenotypes in mice” (opens in new tab), Neurobiology of Aging, vol. 126, pp. 44-57, 2023.
- Bennett CL, La Spada AR, “SUMOylated Senataxin plays pivotal roles in genome stability, RNA degradation, and SG-disassembly, and is linked with Ataxia and ALS4” (opens in new tab), Molecular Genetics and Genomic Medicine, vol. 9, pp. e1745, 2021.
Most Cited Publications
- Bennett CL, Christie J, Ramsdell F, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD, “The Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3” (opens in new tab), Nature Genetics, vol. 27, pp. 20-21, 2001.
- Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De Jonghe P, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DA, Chance PF, “DNA/RNA helicase gene mutations in a form of juvenile Amyotrophic Lateral Sclerosis (ALS4)” (opens in new tab), American Journal of Human Genetics, vol. 74, no. 6, pp. 1128-1135, 2004.
- Parisi MA, Bennett CL, Eckert ML, Dobyns WB, Gleeson JG, Shaw DW, McDonald R, Eddy A, Chance PF, Glass IA, “The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome” (opens in new tab), American Journal of Human Genetics, vol. 75, no. 1, pp. 82-91, 2004.
- Bennett CL, Brunkow ME, Ramsdell FD, O' Briant KC, Zhu Q, Shigeoka A, Ochs HD, Chance PF, “A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome” (opens in new tab), Immunogenetics, vol. 53, pp. 435-439, 2001.
- Street VA, Bennett CL, Goldy JD, Shirk AJ, Kleopa KA, Tempel BL, Lipe HP, Scherer SS, Bird TD, Chance PF, “Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth Disease 1C” (opens in new tab), Neurology, vol. 60, pp. 22-26, 2003.
- Brunkow ME, Bennett CL, Ochs HD, “IPEX is a unique X-linked syndrome characterized by Immune dysfunction, Polyendocrinopathy, Enteropathy and a variety of Autoimmune Phenomena” (opens in new tab), Current Opinion in Pediatrics, vol. 22, pp. 357-368, 2002.
- Bennett CL, Schrader AP, Morris BJ, “Cross-sectional analysis of Met235-Thr variant of angiotensinogen gene in severe, familial hypertension” (opens in new tab), Biochemical and Biophysical Research Communications, vol. 197, no. 2, pp. 833-839, 1993.
- Chen YZ, Hashemi SH, Anderson SK, Huang Y, Moreira MC, Lynch DR, Glass IA, Chance PF, Bennett CL, “Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease” (opens in new tab), Neurobiology of Disease, vol. 23, no. 1, pp. 97-108, 2006.
- Bennett CL, Yoshioka R, Kiyosawa H, Barker D, Fain P, Shigeoka A, Chance PF, “An X-linked Syndrome of Polyendocrinopathy, Immune Dysfunction and Diarrhea (XPID) Maps to Xp11.23-Xq13.3” (opens in new tab), American Journal of Human Genetics, vol. 66, no. 2, pp. 461-468, 2000.
- Bennett CL, Chen YZ, Hahn S, Glass IA, Gospe SM, “Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients” (opens in new tab), Epilepsia, vol. 50, no. 5, pp. 1167–1175, 2009.
Contact Information
Email: craiglb@uci.edu
Phone: (949) 824-7407
Address: 419 S. Circle View Dr. ISEB Room 2500, Irvine, CA 92697-4629
Return to topThis profile was created with the help of AI.
Last updated on 2/19/2026.